Drug Profile
Phx
Alternative Names: Phenoxazine-modified actinomycin analogueLatest Information Update: 04 Apr 2003
Price :
$50
*
At a glance
- Originator Gifu Pharmaceutical University; Tokyo Medical University
- Class Antineoplastics
- Mechanism of Action DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer